ATLANTA, GA (Globe Newswire – May 19, 2026) — Holzer & Holzer, LLC is investigating whether Prestige Consumer Healthcare Inc. (“Prestige Consumer” or the “Company”) (NYSE: PBH) complied with federal securities laws. On May 13, 2026, Prestige Consumer reported fourth quarter and full year 2026 financial results revealing that revenues decreased by 5% compared to the fourth fiscal quarter 2025 and by 4.5% versus the prior fiscal year excluding the impact of foreign currency. During the Company’s earnings call the CEO stated “In Q4, Clear Eyes sales were below expectations due to delayed shipments and production shutdowns ahead of line updates.” The price of the Company’s stock dropped following this news.

If you purchased Prestige Consumer stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at jkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/prestige-consumer/ to discuss your legal rights.